Terms: = Breast cancer AND MAP2K1, MAPKK1, 5604, ENSG00000169032, Q02750, MEK1, MKK1, PRKMK1 AND Clinical Outcome
2 results:
1. Bayesian Network Inference Modeling Identifies TRIB1 as a Novel Regulator of Cell-Cycle Progression and Survival in cancer Cells.
Gendelman R; Xing H; Mirzoeva OK; Sarde P; Curtis C; Feiler HS; McDonagh P; Gray JW; Khalil I; Korn WM
Cancer Res; 2017 Apr; 77(7):1575-1585. PubMed ID: 28087598
[TBL] [Abstract] [Full Text] [Related]
2. Medulloblastoma sensitivity to 17-allylamino-17-demethoxygeldanamycin requires MEK/ERKM.
Calabrese C; Frank A; Maclean K; Gilbertson R
J Biol Chem; 2003 Jul; 278(27):24951-9. PubMed ID: 12709419
[TBL] [Abstract] [Full Text] [Related]
